| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |